211 related articles for article (PubMed ID: 34737698)
1. Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells.
Zhang YZ; Yang JY; Wu RX; Fang C; Lu H; Li HC; Li DM; Zuo HL; Ren LP; Liu XY; Xu R; Wen JH; Huang HD; Hong R; Chen QJ
Front Pharmacol; 2021; 12():714628. PubMed ID: 34737698
[TBL] [Abstract][Full Text] [Related]
2. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
Tu H; Li J; Xu W; Wang Z; Wang L
Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
[TBL] [Abstract][Full Text] [Related]
3. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
[TBL] [Abstract][Full Text] [Related]
4. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
[TBL] [Abstract][Full Text] [Related]
5. Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions.
Li D; Fan H; Dong J; Sun C; Su Y; Liu J; Gu Y
Breast Cancer (Dove Med Press); 2021; 13():725-742. PubMed ID: 34992452
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Regulation Mechanism of Xihuang Pill,
Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L
Front Pharmacol; 2020; 11():825. PubMed ID: 32595497
[TBL] [Abstract][Full Text] [Related]
7. Xihuang pill in the treatment of cancer: TCM theories, pharmacological activities, chemical compounds and clinical applications.
Xu HB; Chen XZ; Wang X; Pan J; Yi-Zhuo Z; Zhou CH
J Ethnopharmacol; 2023 Nov; 316():116699. PubMed ID: 37257709
[TBL] [Abstract][Full Text] [Related]
8. [Effect of serum containing Xihuang pill on proliferation of human breast cancer cell line MDA-MB-435 and MCF-7 Cells].
He LJ; Li JS; Chen X; Zhang HT; Zhu XG; Zhang XD; Xie SH; Gu HO
Zhongguo Zhong Yao Za Zhi; 2018 Jul; 43(13):2784-2788. PubMed ID: 30111032
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer.
Zhao X; Hao J; Chen S
Evid Based Complement Alternat Med; 2020; 2020():6076572. PubMed ID: 32256653
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
11. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
Wu J; Luo D; Li S
Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
[TBL] [Abstract][Full Text] [Related]
12. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
[TBL] [Abstract][Full Text] [Related]
13. The prospect of
Chen Z; Li Z; Yang S; Wei Y; An J
Heliyon; 2023 Apr; 9(4):e15490. PubMed ID: 37128341
[TBL] [Abstract][Full Text] [Related]
14. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of anti-hyperplasia of mammary glands of Xihuang Pills blood-entering component based on UPLC-Q-TOF-MS and network pharmacology].
Fan QR; Chen M; Dong XY; Tao R; Wang JR; Xia SL; Lan YM; Han T
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6749-6764. PubMed ID: 38212035
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of Xihuang pills' intervention in the tumour immune microenvironment for the treatment of liver cancer based on the STAT3-PDL1 pathway.
Wang Y; Wang W; Liu K; Liu Y; Shen X; Li Q; Deng F; Hao X; Wang Y
J Ethnopharmacol; 2024 May; 331():118278. PubMed ID: 38710457
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effects of Xihuang Pill on lung cancer treatment by an integrative approach.
Li C; Chen W; Zhang M; Zhang C; Cao B; Dong B; Qi S; Zhang Y; Fei X; Li X; Li R; Wang J; Li G
Biomed Pharmacother; 2020 Oct; 130():110533. PubMed ID: 32739739
[TBL] [Abstract][Full Text] [Related]
18. An Integrative Metabolomic and Network Pharmacology Study Revealing the Regulating Properties of Xihuang Pill That Improves Anlotinib Effects in Lung Cancer.
Li C; Wang Z; Chen W; Cao B; Zhang M; Gu Q; Qi S; Fei X; Shi Y; Li X; Li R; Wang J; Li G
Front Oncol; 2021; 11():697247. PubMed ID: 34434895
[TBL] [Abstract][Full Text] [Related]
19. Multiple effects of Xihuang pill aqueous extract on the Hs578T triple-negative breast cancer cell line.
Zheng W; Han S; Jiang S; Pang L; Li X; Liu X; Cao M; Li P
Biomed Rep; 2016 Nov; 5(5):559-566. PubMed ID: 27882217
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the mechanisms of dandelion against triple-negative breast cancer using a combined network pharmacology, molecular pharmacology and metabolomics approach.
Qu J; Ke F; Liu Z; Yang X; Li X; Xu H; Li Q; Bi K
Phytomedicine; 2022 May; 99():153986. PubMed ID: 35183931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
